Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Scheidhauer

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
Nuklearmedizin. Nuclear Medicine|December 1, 1993
[Radioiodine therapy in Europe--a survey]H Schicha, K Scheidhauer
Nuklearmedizin. Nuclear Medicine|October 31, 2006
[External therapy with radioactive urine: a pitfall during sceletal scintigraphy]K Scheidhauer, V Urbannek
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 1, 1998
Estrogen receptor scintigraphyK Scheidhauer, A Scharl, H Schicha
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|December 1, 1995
The role of nuclear medicine in diagnosis of catheter-related infectionsK Scheidhauer, H J Deutsch, H Schicha
Der Radiologe|March 20, 2009
[PET-CT for neuroendocrine tumors and nuclear medicine therapy options]K Scheidhauer, M Miederer, F C Gaertner
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2004
FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesionsK Scheidhauer, C Walter, M D Seemann
Minerva Endocrinologica|October 13, 2010
Diagnostic imaging work up in multi-nodular goiterM Luster, F A Verburg, K Scheidhauer
Nuklearmedizin. Nuclear Medicine|March 29, 2002
[Body weight gain after radioiodine therapy in hyperthyroidism]K Scheidhauer, L Odatzidu, P Kiencke, et al.
Nuklearmedizin. Nuclear Medicine|August 1, 1990
[Immunoscintigraphy of the hematopoietic bone marrow in osteomyelofibrosis]P Bartenstein, B Kirchner, K Scheidhauer, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|April 13, 1999
[Quality criteria for cost-benefit analysis in oncologic nuclear medicine and state of its realization]M Dietlein, K Scheidhauer, K W Lauterbach, et al.
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
Nuklearmedizin. Nuclear Medicine|December 1, 1993
[Radioiodine therapy in Europe--a survey]H Schicha, K Scheidhauer
Nuklearmedizin. Nuclear Medicine|October 31, 2006
[External therapy with radioactive urine: a pitfall during sceletal scintigraphy]K Scheidhauer, V Urbannek
The Quarterly Journal of Nuclear Medicine : Official Publication of the Italian Association of Nuclear Medicine (AIMN) [And] the International Association of Radiopharmacology (IAR)|July 1, 1998
Estrogen receptor scintigraphyK Scheidhauer, A Scharl, H Schicha
Zentralblatt Fur Bakteriologie : International Journal of Medical Microbiology|December 1, 1995
The role of nuclear medicine in diagnosis of catheter-related infectionsK Scheidhauer, H J Deutsch, H Schicha
Der Radiologe|March 20, 2009
[PET-CT for neuroendocrine tumors and nuclear medicine therapy options]K Scheidhauer, M Miederer, F C Gaertner
European Journal of Nuclear Medicine and Molecular Imaging|May 11, 2004
FDG PET and other imaging modalities in the primary diagnosis of suspicious breast lesionsK Scheidhauer, C Walter, M D Seemann
Minerva Endocrinologica|October 13, 2010
Diagnostic imaging work up in multi-nodular goiterM Luster, F A Verburg, K Scheidhauer
Nuklearmedizin. Nuclear Medicine|March 29, 2002
[Body weight gain after radioiodine therapy in hyperthyroidism]K Scheidhauer, L Odatzidu, P Kiencke, et al.
Nuklearmedizin. Nuclear Medicine|August 1, 1990
[Immunoscintigraphy of the hematopoietic bone marrow in osteomyelofibrosis]P Bartenstein, B Kirchner, K Scheidhauer, et al.
Zeitschrift Fur Arztliche Fortbildung Und Qualitatssicherung|April 13, 1999
[Quality criteria for cost-benefit analysis in oncologic nuclear medicine and state of its realization]M Dietlein, K Scheidhauer, K W Lauterbach, et al.
Pageof 7